Diminished ovarian reserve (DOR) is a condition seen in women which is characterised by a reduction in the number or quality of eggs found in the ovaries. Unfortunately, as the ovarian reserve diminishes, conception becomes difficult, making infertility a possibility. As one of the leading causes of infertility in women, diminished ovarian reserve can affect women of any reproductive age but is more commonly found in those over the age of 35.
It is essential to be aware of the causes of diminished ovarian reserve so that there is ample time for early detection, timely medical intervention, and informed family planning. In this article, we will examine the full spectrum of medical, genetic, environmental, and lifestyle-related factors that contribute to diminished ovarian reserve.
Every woman is born with her complete lifetime supply of eggs, around one to two million primordial follicles. By the time she reaches puberty, the number drops to around 300,000 to 500,000, and it continues to decline throughout her reproductive years.
Diminished ovarian reserve is diagnosed in women when the follicular pool depletes at a faster rate than expected, as per a woman’s age. It also refers to when the remaining eggs are of insufficient quality to support proper fertilisation and healthy embryo development. While a woman with diminished ovarian reserve can still get pregnant naturally, but the odds are much smaller.
You may not know that you are affected by the condition, as women rarely experience any obvious symptoms other than not getting pregnant despite trying. Regardless, you can still keep an eye out for irregular periods, vaginal dryness, and hot flashes.
Age is one of the most fundamental and universally applicable causes of diminished ovarian reserve. Reduced egg number and reduced egg quality are progressive, irreversible natural processes that increase significantly in incidence in women from their mid-thirties. Their egg reserve decreases dramatically, and by age 37, women only have approximately 1/10 of their original supply left. Chromosomal abnormalities become increasingly prevalent in the remaining eggs.
Diminished ovarian reserve comprises two components. Firstly, follicular atresia is a natural programmed process of cell death that continues without regard to whether the woman is pregnant or not, or if she is using contraception or any other methods that inhibit ovulation. Secondly, aging oocytes exhibit mitochondrial dysfunction, which impairs their ability to complete meiosis accurately. This increases the risk of aneuploidy (abnormal chromosomal numbers).
Reduced quantity combined with declining quality is why advanced maternal age is linked to lower pregnancy rates, higher miscarriage rates, and increased risk of chromosomal conditions in the children.
Several genetic mutations and chromosomal abnormalities contribute to a rapidly declining ovarian reserve. Some of them are:
The inflammation of the ovaries driven by autoantibodies, also known as autoimmune oophoritis, is a recognised yet underdiagnosed cause of diminished ovarian reserve and POI. In this condition, the immune system targets the ovarian tissue, specifically the granulosa and theca cells surrounding the follicles. This then triggers inflammatory destruction. Autoimmune POI is often linked to other endocrine autoimmune disorders like Addison’s disease.
Other autoimmune conditions that are associated with diminished ovarian reserve include systemic lupus erythematosus (SLE), rheumatoid arthritis, myasthenia gravis, and type 1 diabetes mellitus. However, you must keep in mind that the mechanisms here are usually multifactorial, involving both immune-mediated follicular damage and immunosuppressive medications.
Whether it is through direct tissue removal or vascular compromise to the ovarian cortex, prior surgeries near or on the ovaries can pose a high risk of reducing ovarian reserve.
Endometriosis is a condition in which tissue resembling that of the uterine lining grows outside the uterus. This can impair the ovarian reserve either directly or indirectly.
Ovarian endometriomas secrete reactive oxygen species (ROS) and pro-inflammatory mediators, which may have toxic effects on adjacent follicles and accelerate follicular atresia. It has been shown that the follicular fluid of women with endometriosis contains elevated levels of oxidative stress markers that affect oocyte quality, even in morphologically normal follicles.
In addition to direct follicular toxicity, endometriosis causes local inflammation that affects the ovarian microenvironment and granulosa cell function, thereby impairing normal folliculogenesis. Women with endometriosis have consistently lower AMH levels and AFC than age-matched controls without endometriosis, and the decrease is proportional to disease severity.
Alkylating agents such as cyclophosphamide, busulfan, and melphalan are the most potent gonadotoxic cytotoxic agents used in chemotherapy. They induce double-strand breaks in DNA in oocytes and granulosa cells, leading to apoptosis and irreversible follicular depletion. The damage depends on the agent, the cumulative dose, and the patient's age at the time of treatment. Platinum-based agents, taxanes, and anthracyclines have intermediate and lower gonadotoxicity.
On the other hand, radiation to the pelvis or the whole abdomen directly irradiates the ovarian follicles, which are highly radiosensitive. Cranial radiation that includes the hypothalamic-pituitary axis can also lead to decreased gonadotropin secretion, resulting in a functional rather than structural decrease in ovarian stimulation.
Exposure to environmental toxins may also contribute to low ovarian reserve. The toxins that you should watch out for are the following:
Genetic, medical, and environmental factors aside, a woman’s lifestyle also impacts her ovarian reserve. Even though the lifestyle alone does not lead to diminished ovarian reserve, there are certain practices that can affect ovarian ageing and even exacerbate predisposition.
In many cases, particularly those seen in younger women, diminished ovarian reserve does not have an identifiable cause, regardless of investigation. This is known as idiopathic diminished ovarian reserve. It has been hypothesised that in such cases, the cause may lie in unidentified genetic polymorphisms, subclinical autoimmune activity, or subtle mitochondrial dysfunction that is undetectable by current diagnostic tools.
Diminished ovarian reserve is a clinically complex disorder with a broad spectrum of known aetiologies, including advancing age, genetic mutations, autoimmune processes, surgical history, gonadotoxic treatments and environmental exposures. The primary and inevitable reason for the decline of follicles is still age, but many medical and external factors can significantly accelerate this process.
Early assessment of ovarian reserve, especially in women with risk factors for earlymenopausesuch as family history, prior pelvic surgery, cancer treatment or autoimmune disease, allows for timely fertility preservation and better reproductive planning.